O-Desmethyl indomethacin

CAS: 2504-32-7

Ref. 3D-FD21281

Produktinformation

• Name: O-Desmethyl indomethacin
• Synonyme: 1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetic acid5-HydroxyindomethacinDemethylindomethacin, 1-(4-Chlorobenzoyl)-5-Hydroxy-2-Methyl-3-Indoleacetic Acid, 1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetic acid, 1-(p-Chlorobenzoyl)-5-hydroxy-2-methylindole-3-acetic acid, 1H-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-hydroxy-2-methyl-, 2-(1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indol-3-yl)acetic acid, 5-Hydroxyindomethacin, Demethylindomethacin, Desmethylindomethacin, Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-hydroxy-2-methyl-, O-Desmethylindomethacin
• CAS: 2504-32-7

Beschreibung

O-Desmethyl indomethacin is a metabolite of indomethacin that has been shown to be a potent cytotoxic agent and may have potential as an anticancer drug. It inhibits the mitochondrial membrane potential in HL60 cells, which causes significant cytotoxicity. The target tissue for O-desmethyl indomethacin is not known, but it has been shown to be effective against cancer cells in clinical studies. O-Desmethyl indomethacin binds to glucocorticoid receptors in the cytoplasm and inhibits organic anion transporters, leading to its accumulation in urine samples. Studies have also shown that O-desmethyl indomethacin is excreted by infants through breast milk and eliminated with other metabolites through the preparative high performance liquid chromatography (HPLC).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 343.76 g/mol
• Formel: C₁₈H₁₄ClNO₄
• Reinheit: Min. 95%
• InChl: InChI=1S/C18H14ClNO4/c1-10-14(9-17(22)23)15-8-13(21)6-7-16(15)20(10)18(24)11-2-4-12(19)5-3-11/h2-8,21H,9H2,1H3,(H,22,23)
• InChI Key: InChIKey=KMLNWQPYFBIALN-UHFFFAOYSA-N
• SMILES: Cc1c(CC(=O)O)c2cc(O)ccc2n1C(=O)c1ccc(Cl)cc1